Your browser doesn't support javascript.
loading
Development of tetravalent, bispecific CCR5 antibodies with antiviral activity against CCR5 monoclonal antibody-resistant HIV-1 strains.
Schanzer, Jürgen; Jekle, Andreas; Nezu, Junichi; Lochner, Adriane; Croasdale, Rebecca; Dioszegi, Marianna; Zhang, Jun; Hoffmann, Eike; Dormeyer, Wilma; Stracke, Jan; Schäfer, Wolfgang; Ji, Changhua; Heilek, Gabrielle; Cammack, Nick; Brandt, Michael; Umana, Pablo; Brinkmann, Ulrich.
Affiliation
  • Schanzer J; Roche Diagnostics GmbH, Nonnenwald 2, D-82372 Penzberg, Germany. juergen_michael.schanzer@roche.com
Antimicrob Agents Chemother ; 55(5): 2369-78, 2011 May.
Article in En | MEDLINE | ID: mdl-21300827
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV-1 / Antibodies, Bispecific / Receptors, CCR5 Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2011 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV-1 / Antibodies, Bispecific / Receptors, CCR5 Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2011 Type: Article Affiliation country: Germany